Table 1 Baseline characteristics of all studied patients
Descriptive data | ||
|---|---|---|
Age (years), mean ± SD (range) | 46.878 ± 10.605 (30–68) | |
BMI (kg/m2), mean ± SD (range) | 26.232 ± 2.140 (21–31) | |
Gender, n (%) | Male | 55 (61.11%) |
Female | 35 (38.89%) | |
Smoking, n (%) | Smoker | 18 (20%) |
Non-smoker | 72 (80%) | |
Hypertension, n (%) | Hypertensive | 15 (16.67%) |
Normotensive | 75 (83.33%) | |
Diabetes mellitus, n (%) | Diabetic | 7 (7.78%) |
Pre-diabetic | 13 (14.44%) | |
Non-diabetic | 70 (77.78%) | |
FBG (mg/dl), mean ± SD (range) | 89.989 ± 15.786 (66–135) | |
HbA1c (%), mean ± SD (range) | 5.420 ± 0.609 (4.1–7) | |
Child score, n (%) | A5 | 9 (40.91%) 9 (45%) |
A6 | 12 (54.55%) 10 (50%) | |
B7 | 1 (4.55%) 1 (5%) | |
Fibrosis stage, n (%) | F0 | 16 (17.78%) |
F1 | 39 (43.33%) | |
F2 | 10 (11.11%) | |
F3 | 3 (3.33%) | |
F4 | 22 (24.44%) | |
DAA regimen, n (%) | SOF/DCV | 45 (50%) |
SOF/DCV/RBV | 45 (50%) | |
HCV RNA (IU/ml), median (IQR) | 2,253,000 (573,662.25–4,000,000) | |